Provided by Tiger Trade Technology Pte. Ltd.

Indaptus Therapeutics, Inc.

2.08
+0.230012.43%
Pre-market: 2.110.0300+1.44%05:53 EDT
Volume:5.68M
Turnover:12.41M
Market Cap:276.64M
PE:-4.42
High:2.39
Open:1.92
Low:1.89
Close:1.85
52wk High:8.57
52wk Low:0.9200
Shares:133.00M
Float Shares:23.24M
Volume Ratio:3.07
T/O Rate:24.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4709
EPS(LYR):-21.5800
ROE:-318.04%
ROA:-98.08%
PB:24.33
PE(LYR):-0.10

Loading ...

Indaptus Amends 8-K to Update Dilution Disclosure in ATM Prospectus Supplement

Reuters
·
Sep 08

Indaptus Therapeutics Director Tim Ruan Resigns from Board

Reuters
·
Sep 05

Indaptus Therapeutics Enters Amended ATM Equity Distribution Agreement for up to $100 Million Common Stock Offering

Reuters
·
Sep 01

Indaptus Therapeutics Inc: Files for Offering of up to $100 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 31

Indaptus Therapeutics - Proposed Resale of up to 58,895,000 Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Aug 18

Indaptus Q2 Net Loss Narrows as Costs Fall

Reuters
·
Aug 13

Indaptus Therapeutics Q2 EPS USD -0.02

THOMSON REUTERS
·
Aug 13

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 13

Insider Traders Lose US$34k As Indaptus Therapeutics Drops

Simply Wall St.
·
Jul 08

Indaptus Therapeutics Inc - Files for Resale by the Selling Stockholders of up to 18.86 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jun 27

Indaptus Therapeutics - to Issue 20 Mln Shares at $0.6 Per Share - SEC Filing

THOMSON REUTERS
·
Jun 25

Indaptus Therapeutics - Private Placement Gross Proceeds About $12 Mln Before Expenses - SEC Filing

THOMSON REUTERS
·
Jun 25

Indaptus Therapeutics Sells 20,000,000 Shares at $0.6 in $12 Million Private Placement

Reuters
·
Jun 25

Top Premarket Decliners

MT Newswires Live
·
Jun 05

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:47 PM

Reuters
·
Jun 05

Indaptus Therapeutics Q1 net loss narrows as expenses fall

Reuters
·
May 15

Indaptus net loss narrows to $2.5 million in Q1 FY26; R&D expenses drop 82% to $491,134

Reuters
·
May 15

Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 15

Indaptus Therapeutics Q1 EPS USD -0.23

THOMSON REUTERS
·
May 15

Indaptus Therapeutics Inc expected to post a loss of $1.87 a share - Earnings Preview

Reuters
·
May 08